Heubach Colorants India Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 29, 2026

Key Highlights

The Latest Trading Price of Sudarshan Colorants India Ltd is ₹ 280.65 as of 27 Mar 15:30 . The P/E Ratio of Sudarshan Colorants India Ltd changed from 3.9 on March 2021 to 26.2 on March 2025 . This represents a CAGR of 46.37% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Sudarshan Colorants India Ltd changed from ₹ 857.84 crore on March 2021 to ₹ 1350 crore on March 2025 . This represents a CAGR of 9.50% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of Sudarshan Colorants India Ltd for the Dec '25 is ₹ 179.96 crore as compare to the Sep '25 revenue of ₹ 192.6 crore. This represent the decline of -6.56% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sudarshan Colorants India Ltd for the Dec '25 is ₹ 2.79 crore as compare to the Sep '25 ebitda of ₹ 26.76 crore. This represent the decline of -89.57% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sudarshan Colorants India Ltd changed from ₹ 5.17 crore to ₹ -2 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sudarshan Colorants India Ltd changed from 215.3 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sudarshan Colorants India Ltd

Heubach Colorants India Limited, formerly known as Clariant Chemicals (India) Limited was incorporated in 1956 with technical and financial collaboration of Hoechst and Bayer AG and three Indian business groups: the Ruias, the Khataus and Ghias.
Due to change in ownership structure of the Company post -acquisition by SK Capital and Heubach Group, Company changed the name from Clariant Chemicals (India) Limited' to Heubach Colorants India Limited on October 17, 2022.
The Company manufactures and sells pigments, preparations, and dyes for use in the coatings, plastic, printing, non-impact printing (NIP), and special applications in home and personal care, agriculture, stationery, fibres, etc. sectors. In October 2000, 50.1% equity stake of the company held by Hoechest AG, Germany was transferred to EBITO Chemiebeteiligungen AG, Switzerland, a subsidiary of Clariant International AG, Switzerland and subsequently EBITO acquired 20% stake of the company in 2005.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Sudarshan Colorants India Ltd or Saroja Pharma Industries India Ltd?

Market cap of Sudarshan Colorants India Ltd is 647 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd?

As of March 29, 2026, the Sudarshan Colorants India Ltd stock price is INR ₹280.65. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.35.

How do dividend payouts of Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Sudarshan Colorants India Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.